About us

Claritas Genomics is a specialized clinical diagnostic laboratory that focuses on providing high-quality genetic testing and interpretation services for pediatric and rare genetic conditions. The organization collaborates closely with physicians, hospitals, and research institutions to deliver accurate genomic insights that guide patient care and medical decisions. Using advanced next-generation sequencing (NGS) technologies, Claritas offers comprehensive DNA and RNA testing solutions that support diagnosis, treatment planning, and ongoing clinical research.

Founded as a spin-off from Boston Children’s Hospital, Claritas Genomics was established to bridge the gap between cutting-edge genomic research and clinical application. Its mission is to bring clarity to complex genetic data through reliable testing, secure data sharing, and innovative bioinformatics tools. The company’s laboratories maintain high quality standards, following CAP and CLIA certifications to ensure precision and reproducibility in every test.

Claritas Genomics also plays a vital role in promoting data transparency and collaboration within the medical community. It partners with academic and industry leaders to build genomic databases that accelerate the discovery of rare disease variants and improve diagnostic yield. Through these initiatives, the organization not only advances personalized medicine but also empowers clinicians with actionable genetic information that can transform patient outcomes.

With a strong focus on ethics, patient privacy, and scientific excellence, Claritas Genomics continues to be a trusted name in molecular diagnostics. Its commitment to innovation, collaboration, and patient-centered care makes it a key player in shaping the future of genomics and precision healthcare, delivering answers that help families and physicians navigate the challenges of genetic disorders.